MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - Politician Trades
Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.40 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded MGRX stock?
Rallies tracks politician and congressional stock disclosures for MGRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
JOHNSTON EUGENE M sold 3.33K (~$3.88K) on Dec 15, 2025.
JOHNSTON EUGENE M sold 5.00K (~$5.97K) on Dec 9, 2025.
JOHNSTON EUGENE M sold 10.00K (~$11.28K) on Dec 5, 2025.
MGRX Analyst Consensus
MGRX analyst coverage data. Average price target: $0.00.
Common questions about MGRX
Which politicians traded MGRX stock?
Rallies tracks politician and congressional stock disclosures for MGRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in MGRX?
Yes. Rallies tracks politician and congressional stock disclosures for MGRX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is MGRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.